MORABITO, FABIO
 Distribuzione geografica
Continente #
NA - Nord America 287
AS - Asia 112
EU - Europa 77
SA - Sud America 26
AF - Africa 22
Totale 524
Nazione #
US - Stati Uniti d'America 282
SG - Singapore 71
IT - Italia 26
BR - Brasile 22
CI - Costa d'Avorio 21
CN - Cina 18
IE - Irlanda 16
FI - Finlandia 9
VN - Vietnam 6
DE - Germania 5
GB - Regno Unito 5
IN - India 5
CZ - Repubblica Ceca 4
AR - Argentina 3
CA - Canada 3
TR - Turchia 3
JP - Giappone 2
MX - Messico 2
NL - Olanda 2
PL - Polonia 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
SE - Svezia 2
AT - Austria 1
BD - Bangladesh 1
CH - Svizzera 1
CO - Colombia 1
FR - Francia 1
IR - Iran 1
KZ - Kazakistan 1
PH - Filippine 1
UA - Ucraina 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 524
Città #
Dallas 79
Santa Clara 59
Singapore 41
Chicago 26
Abidjan 21
Dublin 16
Civitanova Marche 13
Chandler 11
Ashburn 10
Beijing 10
Los Angeles 10
Boardman 8
Turku 8
Phoenix 5
Andover 4
Cambridge 4
Lawrence 4
Munich 4
Ankara 3
Catania 3
Chennai 3
Des Moines 3
Ho Chi Minh City 3
London 3
Montreal 3
New York 3
Denver 2
Orem 2
Scarsdale 2
Seattle 2
Stockholm 2
São Paulo 2
Tokyo 2
Warsaw 2
Arroio Grande 1
Atlanta 1
Belem 1
Belo Horizonte 1
Bernareggio 1
Blumenau 1
Bofete 1
Boston 1
Boydton 1
Brandywine 1
Brooklyn 1
Buenos Aires 1
Buffalo 1
Campinas 1
Cranston 1
Curitiba 1
Dammam 1
Florianópolis 1
Guaratinguetá 1
Guarujá 1
Guarulhos 1
Gustavo Adolfo Madero 1
Haiphong 1
Itajuípe 1
Itapetinga 1
Jeddah 1
Jequié 1
Johannesburg 1
João Pessoa 1
Lappeenranta 1
Mauá 1
Milan 1
New Delhi 1
Olomouc 1
Popayán 1
Poplar 1
Ramos Mejía 1
Ranchi 1
Redmond 1
Redwood City 1
Rome 1
Santa Fe 1
Santa Maria 1
Santa Rosa 1
Santaluz 1
Sete Lagoas 1
Shymkent 1
Tehran 1
Thái Bình 1
Veranópolis 1
Vũng Tàu 1
Wilmington 1
Totale 425
Nome #
A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia 101
Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study 83
Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: A phase III, open-label, randomized trial 72
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab 68
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study 60
Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment 57
Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases 52
In vitro drug-induced cytotoxicity predicts clinical response to fludarabine in B-cell chronic lymphocytic leukaemia 41
Totale 534
Categoria #
all - tutte 1.907
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.907


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113 0 0 0 0 0 0 10 0 3 0 0 0
2021/202220 0 4 0 0 4 0 4 0 1 0 0 7
2022/202338 4 3 3 1 1 6 0 6 10 0 1 3
2023/202425 0 6 4 1 2 4 0 2 0 0 3 3
2024/2025210 0 39 11 19 41 26 7 2 14 13 25 13
2025/2026228 22 24 74 44 64 0 0 0 0 0 0 0
Totale 534